Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome

Paul T. Dick, MD, CM, FRCPC

  1. Canadian Task Force on the Periodic Health Examination: The periodic health examination. CMAJ 1979; 121: 1193-1254
  2. Proceed with Care: Final Report of the Royal Commission on New Reproductive Technologies, Royal Commission on New Reproductive Technologies, Ottawa, 1994: 804-809
  3. Ethics and Public Policy Committee, Canadian College of Medical Geneticists: Prenatal diagnosis: the medical genetics perspective. CMAJ 1991; 144: 1129-1132
  4. National Institutes of Health Workshop Statement. Reproductive genetic testing: impact on women. Am J Hum Genet 1992; 51: 1161-1163
  5. Beck MN: Eugenic abortion: an ethical critique. CMAJ 1990; 143: 181-186
  6. McDonough P: Congenital disability and medical research: the development of amniocentesis. Women Health 1990; 16: 137-153
  7. Gregg R: "Choice" as a double-edged sword: information, guilt and mother-blaming in a high-tech age. [review] Women Health 1993; 20: 53-73
  8. Goldbloom R., Battista RN: The periodic health examination: 1. Introduction. CMAJ 1986; 134: 721-723
  9. Jones KL: Down syndrome. In Jones KL (ed): Smith's Recognizable Patterns of Human Malformation, 4th ed, WB Saunders, Philadelphia, 1988: 10-15
  10. Adams MM, Erickson JD, Layde PM et al: Down's syndrome. Recent trends in the United States. JAMA 1981; 246: 758-760
  11. Baird PA, Sadovnick AD: Maternal age-specific rates for Down syndrome: changes over time. Am J Med Genet 1988; 29: 917-927
  12. Stoll C, Alembik Y, Dott B et al: Epidemiology of Down syndrome in 118 265 consecutive births. Am J Med Genet Suppl 1990; 7: 79-83
  13. Ferguson-Smith M, Yates JRW: Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52 965 amniocenteses. Prenat Diagn 1984; 4: 5-44
  14. Mikkelsen M: Epidemiology of trisomy 21: population, peri- and antenatal data. In Burgio CR, Fraccaro M, Tiepolo L et al (eds): Trisomy 21, Springer-Verlag, Berlin, 1981: 211-226
  15. Baird PA, Sadovnick AD: Life tables for Down syndrome. Hum Genet 1989; 82: 291-292
  16. Eyman RK, Call TL, White JF: Life expectancy of persons with Down syndrome. Am J Ment Retard 1991; 95: 603-612
  17. Oster J, Mikkelsen M, Nielson A: Mortality and lifetable in Down's syndrome. Acta Paediatr Scand 1975; 64: 322-326
  18. Baird PA, Sadovnick AD: Life expectancy in Down syndrome adults. Lancet 1988; 2: 1354-1356
  19. Cnric, KA: Families with Down syndrome: ecological contexts and characteristics. In Cicchetti D, Beeghly M (eds): Children with Down Syndrome: a Developmental Perspective, Cambridge University Press, Cambridge, England, 1990: 399-423
  20. Gath A: Down syndrome children and their families. Am J Med Genet Suppl 1990; 7: 314-316
  21. Carr J: The effect on the family of a severely mentally handicapped child. In Clarke AM, Clarke ADB, Berg JM (eds): Mental Deficiency: the Changing Outlook, Methuen and Company, London, England, 1985: 512-548
  22. Share JB: Review of drug treatment for Down's syndrome persons. Am J Ment Defic 1976; 80: 388-393
  23. Bidder RT, Gray P, Newcombe RG et al: The effects of multivitamins and minerals on children with Down syndrome. Dev Med Child Neurol 1989; 31: 532-537
  24. Van Dyke DC, Lang DJ, van Duyune S et al: Cell therapy in children with Down syndrome: a retrospective study. Pediatrics 1990; 85: 79-84
  25. Foreman PJ, Ward J: An evaluation of cell therapy in Down syndrome. Aust Paediatr J 1987; 23: 151-156
  26. Gibson D, Harris A: Aggregated early intervention effects for Down's syndrome persons: patterning and longevity of benefits. J Ment Defic Res 1988; 32: 1-17
  27. Aronson M, Fallstrom K: Immediate and long-term effects of developmental training in children with Down's syndrome. Dev Med Child Neurol 1977; 19: 489-494
  28. DiMaio MS, Baumgarten A, Greenstein RM et al: Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. N Engl J Med 1987; 317: 342-346
  29. Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening. Am J Obstet Gynecol 1989; 160: 575-581
  30. Lustig L, Clarke S, Cunningham G et al: California's experience with low MS-AFP results. Am J Med Genet 1988; 31: 211-222
  31. Muller F, Boue A: A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome. Prenat Diagn 1990; 10: 389-398
  32. Cuckle H, Lilford R: Antenatal screening for Down's syndrome. [letter] BMJ 1992; 305: 1017
  33. Macri JN, Kasturi RV, Krantz DA et al: Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. Am J Obstet Gynecol 1990; 165: 1248-1253
  34. Bogart MH, Jones OW: Prenatal screening for fetal Down's syndrome. [editorial] Prenat Diagn 1991; 11: 763-765
  35. Wald NJ, Cuckle HS, Densem JW et al: Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol 1988; 95: 334-341
  36. Canick JA, Knight GJ, Palomaki GE et al: Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynecol 1988; 95: 330-333
  37. Wald NJ, Cuckle HS, Densem JW et al: Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883-887
  38. Reynolds TM, Penney MD: The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy. Ann Clin Biochem 1990; 27: 452-458
  39. Reynolds TM: Software for screening to assess risk of Down's syndrome. [letter] BMJ 1991; 302: 965
  40. Wald NJ, Cuckle HS, Densem JW et al: Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 1992; 99: 144-149
  41. Reynolds TM, Penney MD, Hughes H: Ultrasonographic dating of pregnancy causes significant errors in Down syndrome risk assessment that may be minimized by use of biparietal diameter-based means. Am J Obstet Gynecol 1992; 166: 872-877
  42. Gardosi J, Mongelli M: Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome. BMJ 1993; 306: 1509-1511
  43. Haddow, Palomaki GE, Knight GJ et al: Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992; 327: 588-593
  44. Phillips OP, Elias S, Shulman LP et al: Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Obstet Gynecol 1992; 80: 353-358
  45. Wald NJ, Kennard A, Densem JW et al: Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ 1992; 305: 391-394
  46. Cheng EY, Luthy DA, Zebelman AM, et al: A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol 1993; 81: 72-77
  47. Piggott M, Wilkinson P, Bennett J: Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). J Med Screening 1992; 1: 45-49
  48. Wilson R, Chitayat D, McGillivray BC: Fetal ultrasound abnormalities: correlation with fetal karyotype, autopsy findings and post-natal outcome - a five-year prospective study. Am J Med Genet 1992; 44: 586-590
  49. Nyberg DA, Resta RG, Luthy DA et al: Prenatal sonographic findings of Down syndrome: review of 94 cases. Obstet Gynecol 1990; 76: 370-377
  50. Crane JP, Gray DL: Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome: results of a prospective clinical trial. Obstet Gynecol 1991; 77: 533-536
  51. Grandjean H, Sarramon MF: Sonographic measurement of nuchal skinfold thickness for detection of Down syndrome in second-trimester fetus: a multicenter prospective study. Obstet Gynecol 1995; 85: 103-106
  52. Rotmensch S, Luo JS, Liberati M et al: Fetal humeral length to detect Down syndrome. Am J Obstet Gynecol 1992; 166: 1330-1334
  53. Hill LM, Guzick D, Belfar HL et al: The current role of sonography in the detection of Down syndrome. Obstet Gynecol 1989; 74: 620-623
  54. Hook EB: Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol 1981; 58: 282-285
  55. Hook EB, Fabia JJ: Frequency of Down syndrome in livebirths by single-year maternal age interval: results of a Massachusetts study. Teratology 1978; 17: 223-228
  56. Hook EB, Lindsjo A: Down syndrome in live births by single year maternal age interval in a Swedish study: comparison with results from a New York State study. Am J Hum Genet 1978; 30: 19-27
  57. Trimble BK, Baird PA: Maternal age and Down syndrome: age-specific incidence rates by single-year intervals. Am J Med Genet 1978; 2: 1-5
  58. Sutherland GR, Clisby SR, Bloor G et al: Down's syndrome in South Australia. Med J Aust 1979; 2: 58-61
  59. Young ID, Williams EM, Newcombe RG: Down syndrome and maternal age in South Glamorgan. J Med Genet 1980; 17: 433-436
  60. Hook EB, Chambers GM: Estimated rates of Down syndrome in live births by one year maternal age intervals for mothers aged 20-49 in a New York State study - implications of the risk figures for genetic counseling and cost-benefit analysis of prenatal diagnosis programs. Birth Defects 1977; 13 (3A): 123-141
  61. Huether CA, Gummere GR, Hook EB et al: Down's syndrome: percentage reporting on birth certificates and single year maternal age risk rates for Ohio 1970-79: comparison with upstate New York data. Am J Public Health 1981; 71: 1367-1372
  62. Koulischer L, Gillerot Y: Down's syndrome in Wallonia (South Belgium), 1971-1978: cytogenetics and incidence. Hum Genet 1980; 54: 243-250
  63. Cuckle HS, Wald NJ, Thompson SG: Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387-402
  64. Hook EB: Differences between rates of trisomy 21 (Down syndrome) and other chromosomal abnormalities diagnosed in livebirths and in cells cultured after second-trimester amniocentesis - suggested explanations and implications for genetic counseling and program planning. Birth Defects 1978; 14 (6C): 249-267
  65. Hook EB, Topol BB, Cross PK: The natural history of cytogenetically abnormal fetuses detected at midtrimester amniocentesis which are not terminated electively: new data and estimates of the excess and relative risk of late fetal death associated with 47,+21 and some other abnormal karyotypes. Am J Hum Genet 1989; 45: 855-861
  66. Stene J, Stene E, Stengel-Rutkowski S et al: Paternal age and Down's syndrome: data from prenatal diagnoses (DFG). Hum Genet 1981; 59: 119-124
  67. Stene E, Stene J, Stengel-Rutkowski S: A reanalysis of the New York State prenatal diagnosis data on Down's syndrome and paternal age effects. Hum Genet 1987; 77: 299-302
  68. Matsunaga, E, Tonomura A, Oishi H et al: Re-examination of paternal effect in Down's syndrome. Hum Genet 1978; 40: 259-268
  69. Stene J, Mikkelsen M: Down syndrome and other chromosomal disorders. In Wald NJ (ed): Antenatal Screening, Oxford University Press, Oxford, England, 1984: 74-105
  70. Cross PK, Hook EB: An analysis of paternal age and 47,+21 in 35 000 new prenatal cytogenetic diagnosis data from the New York State Chromosome Registry: no significant effect. Hum Genet 1987; 77: 307-316
  71. Hook EB: Issues in analysis of data on paternal age and 47,+21: implications for genetic counseling for Down syndrome. Hum Genet 1987; 77: 303-306
  72. Hook EB, Cross PK: Paternal age and Down's syndrome genotypes diagnosed prenatally: no association in New York state data. Hum Genet 1982; 62: 167-174
  73. Roth MP, Stoll C, Taillemite JL et al: Paternal age and Down's syndrome diagnosed prenatally: no association in French data. Prenat Diagn 1983; 3: 327-335
  74. Carter C, Evans KA: Risk of parents who have had one child with Down's syndrome (mongolism) having another child similarly affected. Lancet 1961; 2: 785-788
  75. Stene J: Detection of higher recurrence risk for age dependent chromosome abnormalities with application to G1 (Down syndrome). Hum Hered 1970; 20: 112-122
  76. Mikkelsen M, Stene J: Previous child with Down's syndrome and other chromosome aberration. In Murken JD, Stengel-Rutkowski S, Schwinger E (eds): Prenatal Diagnosis: Proceedings of the 3rd European Conference on Prenatal Diagnosis of Genetic Disorders, Ferdinand Enke, Stuttgart, Germany, 1979: 22-33
  77. Boue A, Gallano P: A collaborative study of the segregation of inherited chromosome structural rearrangements in 1356 prenatal diagnoses. Prenat Diagn 1984; 4: 45-67
  78. Stene J: Statistical inference on segregation ratios for D/G translocations, when the families are ascertained in different ways. Ann Hum Genet 1970; 34: 93-115
  79. Stene J: A statistical segregation analysis of (21q22q)-translocations. Hum Hered 1970; 20: 465-472
  80. Haddow JE, Palomaki GE, Knight GJ et al: Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 1994; 330: 1114-1118
  81. Tabor A, Philip J, Madsen M et al: Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 1: 1287-1292
  82. National Institute of Child Health and Human Development National Registry for Amniocentesis Study Group: Midtrimester amniocentesis for prenatal diagnosis. JAMA 1976; 236: 1471-1476
  83. Medical Research Council Working Party on Amniocentesis: An assessment of the hazard of amniocentesis. Br J Obstet Gynaecol 1978; 85 (suppl 2): 1-41
  84. Simpson NE, Dallaire L, Miller JR et al: Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. CMAJ 1976; 115: 739-748
  85. Williamson RA, Varner MW, Grant SS: Reduction in amniocentesis risks using real-time needle guide procedure. Obstet Gynecol 1985; 65: 751-755
  86. Weiner C, Williamson RA, Grant SS et al: Safety of amniocentesis. [letter] Lancet 1986; 2: 225-226
  87. Vyas H, Milner AD, Hopkin IE: Amniocentesis and fetal lung development. Arch Dis Child 1982; 57: 627-628
  88. Lippman A, Tomkins DJ Shime J et al: Multicentre randomized clinical trial of chorion villus sampling and amniocentesis. Final report. Prenat Diagn 1992; 12: 385-408
  89. Tabor A, Philip J, Bang J et al: Needle size and risk of miscarriage after amniocentesis. [letter] Lancet 1988; 1: 183-184
  90. Porreco RP, Young PE, Resnik R et al: Reproductive outcome following amniocentesis for genetic indications. Am J Obstet Gynecol 1982; 143: 653-660
  91. Finegan JA, Quarrington BJ, Hughes HE et al: Child outcome following mid-trimester amniocentesis: development, behavior, and physical status at age 4 years. Br J Obstet Gynaecol 1990; 97: 32-40
  92. Jahoda MG, Pijpers L, Reuss A et al: Evaluation of transcervical chorionic villus sampling with a completed follow-up of 1550 consecutive pregnancies. Prenat Diagn 1989; 9: 621-628
  93. Leschot NJ, Wolf H, Van Prooijen-Knegt AC et al: Cytogenetic findings in 1250 chorionic villus samples obtained in the first trimester with clinical follow-up of the first 1000 pregnancies. Br J Obstet Gynaecol 1989; 96: 663-670
  94. Brambati B, Oldrini A, Ferrazzi E et al: Chorionic villus sampling: an analysis of the obstetric experience of 1000 cases. Prenat Diagn 1987; 7: 157-169
  95. Simoni G, Gimelli G, Cuoco C: First trimester fetal karyotyping: one thousand diagnoses. Hum Genet 1986; 72: 203-209
  96. Hogge WA, Schonberg SA, Golbus MS: Chorionic villus sampling: experience of the first 1000 cases. Am J Obstet Gynecol 1986; 154: 1249-1252
  97. Green JE, Dorfmann A, Jones SL et al: Chorionic villus sampling: experience with an initial 940 cases. Obstet Gynecol 1988; 71: 208-212
  98. Wilson RD, Kendrick V, Wittman BK et al: Spontaneous abortion and pregnancy outcome after normal first-trimester ultrasound examination. Obstet Gynecol 1986; 67: 352-355
  99. Simpson JL, Mills JL, Holmes LB et al: Low fetal loss rates after ultrasound-proved viability in early pregnancy JAMA 1987; 258: 2555-2557
  100. Cashner KA, Christopher CR, Dysert GA: Spontaneous fetal loss after demonstration of a live fetus in the first trimester. Obstet Gynecol 1987; 70: 827-830
  101. Gilmore DH, McNay MB: Spontaneous fetal loss in early pregnancy. [letter] Lancet 1985; 1: 107
  102. Mastroiacovo P, Botto LD: Chorionic villus sampling and transverse limb deficiencies: maternal age is not a confounder. Am J Med Genet 1994; 53: 182-186
  103. Olney RS, Khoury MJ, Alo CJ et al: Increased risk for transverse digital deficiency after chorionic villus sampling: results of the United States Multistate Case-Control Study, 1988-1992. Teratology 1995; 51: 20-29
  104. Dolk H, Bertrand F, Lechat MF for the EUROCAT Working Group: Chorionic villus sampling and limb abnormalities. [letter] Lancet 1992; 339: 876-877
  105. Smidt-Jensen S, Permin M, Philip J et al: Randomized comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet 1992; 340: 1237-1244
  106. Jackson L, Zachary JM, Fowler SE et al: A randomized comparison of transcervical and transabdominal chorionic-villus sampling. N Engl J Med 1992; 327: 594-598
  107. Brambati B, Terzian E, Tognoni G: Randomized clinical trial of transabdominal versus transcervical chorionic villus sampling methods. Prenat Diagn 1991; 11: 285-293
  108. Medical Research Council European Trial of chorion villus sampling. MRC working party on the evaluation of chorion villus sampling. Lancet 1991; 337: 1491-1499
  109. Association of Cytogenetic Technologists Task Force: Chromosome analysis guidelines - preliminary report. Cytogenet Cell Genet 1990; 54: 1-4
  110. Grant AM: Chorion villus sampling compared with amniocentesis. [review no. 06007, Apr 2, 1992] In Enkin MW, Keirse MJNC, Renfrew MJ et al (eds): Pregnancy and Childbirth Module, Cochrane Database of Systematic Reviews, disk issue 2, Cochrane Updates on Disk, Update Software, Oxford, England, 1993
  111. Orrell RW, Lilford RJ: Chorionic villus sampling and rare side effects: will a randomized controlled trial detect them? Int J Gynecol Obstet 1990; 32: 29-34
  112. Hakim-Elahi E, Tovell HM, Burnhill MS: Complications of first-trimester abortion: a report of 170 000 cases. Obstet Gynecol 1990; 76: 129-135
  113. Harman CR, Fish DG, Tyson JE: Factors influencing morbidity in termination of pregnancy. Am J Obstet Gynecol 1981; 139: 333-337
  114. Martin MC, Gelfand MM: Mid-trimester abortions: a decade in review. Can J Surg 1982; 25: 641-643
  115. Lawson HW, Atrash HK, Franks AL: Fatal pulmonary embolism during legal induced abortion in the United States from 1972 to 1985. Am J Obstet Gynecol 1990; 162: 986-990
  116. Sjogren B, Uddenberg N: Prenatal diagnosis and psychological distress: amniocentesis or chorionic villus biopsy. Prenat Diagn 1989; 9: 477-487
  117. Evers-Kiebooms G, Swerts A, van den Berghe H: Psychological aspects of amniocentesis: anxiety feelings in three different risk groups. Clin Genet 1988; 33: 196-206
  118. Sjogren B, Uddenberg N: Perinatal diagnosis for psychological reasons: comparison with other indications, advanced maternal age, and known genetic risk. Prenat Diagn 1990; 10: 111-120
  119. Michelacci L, Fava GA, Trombini G et al: Psychological distress and amniocentesis. Gynecol Obstet Invest 1984; 18: 40-44
  120. Robinson GE, Garner DM, Olmstead MP et al: Anxiety reduction after chorionic villus sampling and genetic amniocentesis. Am J Obstet Gynecol 1988; 159: 953-956
  121. Tunis SL, Golbus MS, Copeland KL et al: Patterns of mood states in pregnant women undergoing chorionic villus sampling or amniocentesis. Am J Med Genet 1990; 37: 191-199
  122. Spencer JW, Cox DN: A comparison of chorionic villi sampling and amniocentesis: acceptability of procedure and maternal attachment to pregnancy. Obstet Gynecol 1988; 72: 714-718
  123. Astbury J, Walters WA: Amniocentesis in the early second trimester of pregnancy and maternal anxiety. Aust Fam Physician 1979; 8: 595-597
  124. Fava GA, Kellner R, Michelacci L et al: Psychological reactions to amniocentesis: a controlled study. Am J Obstet Gynecol 1982; 143: 509-513
  125. Heckerling PS, Verp MS, Hadro TA: Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: comparison of patients' choices and those of a decision-analytic model. J Clin Epidemiol 1994; 47: 1215-1228
  126. Cutillo DM, Hammond EA, Reeser SL et al: Chorionic villus sampling utilization following reports of a possible association with fetal limb defects. Prenat Diagn 1994; 14: 327-332
  127. Abuelo DN, Hopmann MR, Barsel-Bowers G et al: Anxiety in women with low maternal serum alpha-fetoprotein screening result. Prenat Diagn 1991; 11: 381-385
  128. Marteau TM, Kidd J, Cook R et al: Psychological effects of having amniocentesis: are these due to the procedure, the risk or the behaviour? J Psychosom Res 1992; 36: 395-402
  129. Marteau TM, Kidd J, Michie S et al: Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial. J Psychosom Obstet Gynaecol 1993; 14: 185-196
  130. Keenan KL, Basso D, Goldkrand J et al: Low level of maternal serum alpha-fetoprotein: its associated anxiety and the effects of genetic counselling. Am J Obstet Gynecol 1991; 164: 54-56
  131. Elder SH, Laurence KM: The impact of supportive intervention after second trimester termination of pregnancy for fetal abnormality. Prenat Diagn 1991; 11: 47-54
  132. Zeanah CH, Dailey JV, Rosenblatt MJ et al: Do women grieve after termination pregnancies because of fetal anomalies? A controlled investigation. Obstet Gynecol 1993; 82: 270-275
  133. Marteau TM, Kidd J, Cook R et al: Perceived risk not actual risk predicts uptake of amniocentesis. Br J Obstet Gynecol 1991; 98: 282-286
  134. Sjogren B, Marsk L: Information on prenatal diagnosis at the antenatal clinic. The women's experiences. Acta Obstet Gynecol Scand 1989; 68: 35-40
  135. Thornton JG, Lilford RJ: Prenatal diagnosis of Down's syndrome: a method for measuring the consistency of women's decisions. Med Decis Making 1990; 10: 288-293
  136. Evans MI, Bottoms SF, Critchfield GC et al: Parental perceptions of genetic risk: correlation with choice of prenatal diagnostic procedures. Int J Gynaecol Obstet 1990; 31: 25-28
  137. Ekwo EE, Kim JO, Gosselink CA: Parental perceptions of the burden of genetic disease. Am J Med Genet 1987; 28: 955-963
  138. Drugan A, Greb A, Johnson MP et al: Determinants of parental decisions to abort for chromosomal abnormalities. Prenat Diagn 1990; 10: 483-490
  139. Youings S, Gregson N, Jacobs P: The efficacy of maternal age screening for Down's syndrome in Wessex. Prenat Diagn 1991; 11: 419-425
  140. Bell J, Hilden J, Bowling F et al: The impact of prenatal diagnosis on the occurrence of chromosome abnormalities. Prenat Diagn 1986; 6: 1-11
  141. Wilson N, Bickley D, McDermott A: The prevention of Down's syndrome in the south western region of England 1975-1985. West Engl Med J 1990; 105: 15-17
  142. Cuckle H, Nanchahal K, Wald N: Birth prevalence of Down's syndrome in England and Wales. Prenat Diagn 1991; 11: 29-34
  143. Mikkelsen M, Fischer G, Hansen J et al: The impact of legal termination of pregnancy and of prenatal diagnosis on the birth prevalence of Down syndrome in Denmark. Ann Hum Genet 1983; 47: 123-131
  144. Luthy DA, Emanuel I, Hoehn H et al: Prenatal genetic diagnosis and elective abortion in women over 35: utilization and relative impact on the birth prevalence of Down syndrome in Washington State. Am J Med Genet 1980; 7: 375-381
  145. Gill M, Murday V, Slack J: An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha-fetoprotein concentration. Soc Sci Med 1987; 24: 725-731
  146. Swint JM, Greenberg F: Maternal serum alpha-fetoprotein screening for Down syndrome: economic considerations. Am J Med Genet 1988; 31: 231-245
  147. Sheldon TA, Simpson J: Appraisal of a new scheme for prenatal screening for Down's syndrome. BMJ 1991; 302: 1133-1136
  148. Goldstein H: Studies of various aspects of Down syndrome in Denmark, and their use as an epidemiological basis for a cost benefit analysis of genetic amniocentesis. Dan Med Bull 1992; 39: 489-508
  149. Shackley P, McGuire A, Boyd PA et al: An economic appraisal of alternative pre-natal screening programmes for Down's syndrome. J Public Health Med 1993; 15: 175-184
  150. American Academy of Pediatrics Committee on Genetics: Alpha-fetoprotein screening. Pediatrics 1987; 80: 444-445
  151. Garver KL: Update on MSAFP policy statement from the American Society of Human Genetics. Am J Hum Genet 1989; 45: 332-334
  152. US Preventive Services Task Force: Guide to Clinical Preventative Services: an Assessment of the Effectiveness of 169 Interventions, Williams and Wilkins, Baltimore, Md, 1989: 225-232
  153. Canadian College of Medical Geneticists and Society of Obstetricians and Gynaecologists of Canada: Canadian guidelines for prenatal diagnosis of genetic disorders: an update 1993. J Soc Obstet Gynecol Can 1993; Mar (suppl): 15-39
  154. Grant AM: Genetic amniocentesis at 16 weeks gestation. [review no 04002, Apr 2, 1992] In Enkin MW, Keirse MJNC, Renfrew MJ et al (eds): Pregnancy and Childbirth Module, Cochrane Database of Systematic Reviews, disk issue 2, Cochrane Updates on Disk, Update Software, Oxford, England, 1993
  155. Grant AM: Ultrasound guidance during 2nd trimester amniocentesis. [review no 06588, Apr 30, 1993] In Enkin MW, Keirse MJNC, Renfrew MJ et al (eds): Pregnancy and Childbirth Module, Cochrane Database of Systematic Reviews, disk issue 2, Cochrane Updates on Disk, Update Software, Oxford, England, 1993
  156. Grant AM: Early amniocentesis vs chorion villus sampling. [review no 07791, Oct 1, 1993] In Enkin MW, Keirse MJNC, Renfrew MJ et al (eds): Pregnancy and Childbirth Module, Cochrane Database of Systematic Reviews, disk issue 2, Cochrane Updates on Disk, Update Software, Oxford, England, 1993
  157. Grant AM: Transabdominal vs transcervical CVS. [review no 06005, May 21, 1993] In Enkin MW, Keirse MJNC, Renfrew MJ et al (eds): Pregnancy and Childbirth Module, Cochrane Database of Systematic Reviews, disk issue 2, Cochrane Updates on Disk, Update Software, Oxford, England, 1993
  158. Chorionic villus sampling and amniocentesis: recommendations for prenatal counselling. MMWR 1995; 44 (RR-9): 1-12